Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
3
×
life sciences
medicare
3
×
merck
3
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
cancer
cell therapy
clinical trials
diagnostics
drug prices
immunotherapy
nivolumab
pembrolizumab keytruda
What
drug
bio
new
roundup
advantages
approval
away
bar
biogen’s
biopharmaceutical
bringing
brings
ceos
companies
convo
dc
earlier
executives
expect
failures
gamble
gathered
groups
hearing
held
littered
lower
market
medco’s
mover
nash
news
patients
payers
pharma
pharmaceutical
physicians
plan
price
prices
Language
unset
Current search:
merck
×
medicare
×
" san francisco top stories "
×
" indiana top stories "
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away